# DESCRIPTION

- introduce turbidimetric immunoassay for assessing human Cystatin C

## BACKGROUND OF THE INVENTION

- motivate Cystatin C as a marker for glomerular filtration rate
- describe limitations of creatinine as a marker
- summarize history of Cystatin C measurement methods
- describe advantages and limitations of nephelometric and turbidimetric methods
- discuss need for improvements in turbidimetric immunoassays
- motivate homogeneous immunoassay systems

## SUMMARY OF THE INVENTION

- introduce improved turbidimetric immunoassay method using nanoparticle-antibody conjugates

## Definitions of General Terms

- define body liquid sample and analyte
- define homogeneous immunoassays, particle enhanced turbidimetric measurements, and other terms

## DETAILED DESCRIPTION OF THE INVENTION

### a) Aspects of the Present Invention

- define particle enhanced turbidimetric immunoassay
- describe nanoparticle-antibody conjugate preparation
- outline turbidity measurement and data analysis
- discuss applications and variations of the invention

### b) Preparation of Anti-Human Cystatin C Antibodies

- prepare polyclonal antibodies
- motivate use of avian antibodies
- describe purification of polyclonal antibodies
- describe affinity purification of polyclonal antibodies
- prepare monoclonal antibodies
- describe chimeric and recombinant antibodies
- describe antibody fragments

### c) Nanoparticles and their Conjugates with Antibody

- describe materials for nanoparticles
- describe conjugation of antibodies to nanoparticles
- describe optimal antibody percentage on nanoparticles
- describe coating of antibodies onto nanoparticles with hydrophilic inert proteins

### d) Preferred Embodiments of the Claimed Turbidimetric Method

- describe advantages of invention
- outline specific improvements at different test conditions
- summarize results under identical conditions with prior art turbidimetric system
- motivate need for improved turbidimetric immunoassay
- describe limitations of prior art turbidimetric methods
- introduce improved turbidimetric immunoassay methods
- describe preferred embodiments of turbidimetric method
- perform assay method of present invention
- describe assay buffer mixtures and constituents
- describe medical uses of assay method
- provide reagent sets and analytical products for assay
- illustrate method of invention with non-limiting examples

## EXPERIMENTAL PART

### Preparation of Polyclonal Avian Serum and Affinity Purification thereof

- prepare polyclonal avian serum and affinity purify

### Preparation of Monoclonal Anti-Human Cystatin C Antibodies

- prepare monoclonal anti-human Cystatin C antibodies

### Preparation of Anti-Cystatin C Immunoparticles

- couple antibodies to latex particles
- prepare coated nanoparticles

### Turbidimetric Cystatin C Assay Based on Immunoparticles of the Present Invention Under Different Assay Conditions

- perform turbidimetric Cystatin C assay

### Assay Example 2

- investigate triglyceride interference
- describe equipment
- list reagents
- prepare samples
- determine Cystatin C concentration
- perform analytical runs
- analyze net results
- conclude on interference
- compare with prior art assay

